Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Moellering

Showing results (141-150 of 235) with videos related to

Pageof 24
Sort By:
The Journal of Antimicrobial Chemotherapy|November 1, 1987
Comparative in-vitro activity of A-56268 (TE-031), a new macrolide antibioticG M Eliopoulos, E Reiszner, M J Ferraro, et al.
Antimicrobial Agents and Chemotherapy|November 11, 1992
Influence of high-level gentamicin resistance and beta-hemolysis on susceptibility of enterococci to the bactericidal activities of ampicillin and vancomycinE Cercenado, G M Eliopoulos, C B Wennersten, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1999
Activities of the oxazolidinones linezolid and eperezolid in experimental intra-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faeciumT Schülin, C Thauvin-Eliopoulos, R C Moellering, et al.
The Journal of Antimicrobial Chemotherapy|October 24, 1998
In-vitro activity of the new ketolide antibiotic HMR 3647 against gram-positive bacteriaT Schülin, C B Wennersten, R C Moellering, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1988
Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compoundsJ S Daly, G M Eliopoulos, E Reiszner, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1985
In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620G M Eliopoulos, A E Moellering, E Reiszner, et al.
Journal of Clinical Microbiology|June 1, 1979
Isolation of Mycoplasma bovis from a patient with systemic illnessS Madoff, B Q Pixley, R A DelGiudice, et al.
Antimicrobial Agents and Chemotherapy|October 11, 1992
Absence of synergistic activity between ampicillin and vancomycin against highly vancomycin-resistant enterococciE Cercenado, G M Eliopoulos, C B Wennersten, et al.
The Journal of Antimicrobial Chemotherapy|August 1, 1993
Efficacy of ceftriaxone plus tazobactam in a rat model of intraabdominal abscess due to Bacteroides fragilisA Pefanis, C Thauvin-Eliopoulos, G M Eliopoulos, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1990
In vitro activity of BAY v 3522, a new cephalosporin for oral administrationT L Hodges, G M Eliopoulos, K Klimm, et al.
Pageof 24

Showing results (141-150 of 235) with videos related to

Sort By:
Pageof 24
The Journal of Antimicrobial Chemotherapy|November 1, 1987
Comparative in-vitro activity of A-56268 (TE-031), a new macrolide antibioticG M Eliopoulos, E Reiszner, M J Ferraro, et al.
Antimicrobial Agents and Chemotherapy|November 11, 1992
Influence of high-level gentamicin resistance and beta-hemolysis on susceptibility of enterococci to the bactericidal activities of ampicillin and vancomycinE Cercenado, G M Eliopoulos, C B Wennersten, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1999
Activities of the oxazolidinones linezolid and eperezolid in experimental intra-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faeciumT Schülin, C Thauvin-Eliopoulos, R C Moellering, et al.
The Journal of Antimicrobial Chemotherapy|October 24, 1998
In-vitro activity of the new ketolide antibiotic HMR 3647 against gram-positive bacteriaT Schülin, C B Wennersten, R C Moellering, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1988
Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compoundsJ S Daly, G M Eliopoulos, E Reiszner, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1985
In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620G M Eliopoulos, A E Moellering, E Reiszner, et al.
Journal of Clinical Microbiology|June 1, 1979
Isolation of Mycoplasma bovis from a patient with systemic illnessS Madoff, B Q Pixley, R A DelGiudice, et al.
Antimicrobial Agents and Chemotherapy|October 11, 1992
Absence of synergistic activity between ampicillin and vancomycin against highly vancomycin-resistant enterococciE Cercenado, G M Eliopoulos, C B Wennersten, et al.
The Journal of Antimicrobial Chemotherapy|August 1, 1993
Efficacy of ceftriaxone plus tazobactam in a rat model of intraabdominal abscess due to Bacteroides fragilisA Pefanis, C Thauvin-Eliopoulos, G M Eliopoulos, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1990
In vitro activity of BAY v 3522, a new cephalosporin for oral administrationT L Hodges, G M Eliopoulos, K Klimm, et al.
Pageof 24